FolioLanternBeta
JAZZJazz Pharmaceuticals plc

Patrick Enright

Director at Jazz Pharmaceuticals plc, as of Sep 2, 2026No sales or purchases in the past 12 months.

Updated Oct 15, 2026 from SEC filings · covers Oct 16, 2025 to Oct 15, 2026
21K
shares held after the latest filing, Jazz Pharmaceuticals plc
Vested shares reported on Forms 3, 4 and 5 only. Not the insider's whole wealth.
3
companies filed for

Last filing: Sep 2, 2026. Most recent sale before this period: Aug 14, 2023. Most recent purchase on record: May 11, 2010.

Pattern

What the filings show, past 12 months. Nothing here rates or predicts.

Roles from filings

Every company we track where this person has filed, newest filing first.

CompanyTitleFirst filingLatest filing
Jazz Pharmaceuticals plc (JAZZ)DirectorJul 9, 2009Sep 2, 2026
Veradermics, Inc (MANE)DirectorFeb 3, 2026Feb 5, 2026
Corcept Therapeutics Inc (CORT)Former DirectorApr 4, 2008Mar 20, 2017

Also a director at

Veradermics, Inc (MANE), Corcept Therapeutics Inc (CORT) (no filing in the last 18 months)

Recent filings

The last 2 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.

This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.